Robert Finney, MD
Procedural Dermatology · New York, NYNPI 1013208487
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by AbbVie at 37.3% of the total. Reporting peaked in 2021 at $7,632 and has fallen 94.3% since, to $436 in 2025.
Across 336 payments — averaging $56.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$4K
- Galderma Laboratories, L.p.$3K
- Johnson & Johnson$543
- Novartis$516
- Sun Pharmaceutical Industries Inc.$422
- plus $3K from 20 others
What the payments were for
- Consulting fees$5,62230%
- Speaking & faculty fees$3,68019%
- Travel & lodging$310%
- Food & beverage$9,41850%
- Education$1671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $7,055 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $4,462 |
| Galderma Laboratories, L.p. | 60 | $3,169 |
| Johnson & Johnson | 18 | $543 |
| Novartis | 42 | $516 |
| Sun Pharmaceutical Industries Inc. | 19 | $422 |
| Merz North America, Inc. | 2 | $317 |
| Lilly USA, LLC | 12 | $265 |
| Regeneron Healthcare Solutions, Inc. | 10 | $254 |
| LEO Pharma Inc. | 12 | $244 |
| Almirall LLC | 14 | $220 |
| Amgen | 9 | $216 |
| E.r. Squibb & Sons, L.L.C. | 8 | $186 |
| Pfizer | 9 | $181 |
| VYNE Pharmaceuticals Inc. | 8 | $148 |
| Arcutis Biotherapeutics, Inc. | 9 | $142 |
| Journey Medical Corporation | 6 | $129 |
| EPI Health, LLC | 5 | $96 |
| Sanofi | 4 | $84 |
| UCB, Inc. | 3 | $67 |
| Encore Dermatology Inc. | 3 | $50 |
| Dermavant Sciences, Inc. | 2 | $48 |
| Incyte Corporation | 2 | $40 |
| Dermira, Inc. | 1 | $24 |
| Biofrontera Inc. | 1 | $21 |
| Aclaris Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,918 in reported general payments places this provider in the 75th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other procedural dermatology in New York
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Ariel OstadNew York$36K
- Elizabeth HaleNew York$34K
- Heidi WaldorfNew York$29K
- Shera AranoffNew York$8K
- Lisa RothmanNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.